Characteristics of Adults With Non‐Hospitalized Severe Respiratory Illness: Findings From a COVID‐19 Vaccine Effectiveness Evaluation in Kenya, 2022–2023

Documenti analoghi

• Costs of Influenza Illness and Acute Respiratory Infections by Household Income Level: Catastrophic Health Expenditures and Implications for Health Equity
  di: Natalie Wodniak, et al.
  Pubblicazione: (2025)
• Quantified impacts of non‐pharmaceutical interventions on influenza circulation during the COVID‐19 pandemic in 13 African countries, 2020–2022
  di: Radhika Gharpure, et al.
  Pubblicazione: (2024)
• Aetiological Fraction of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens in Infants Aged < 1 Year Hospitalised With Respiratory and Non‐Respiratory Medical Illness in South Africa, 2016–2018
  di: Nicole Wolter, et al.
  Pubblicazione: (2025)
• Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus
  di: Ann R. Falsey, et al.
  Pubblicazione: (2024)
• Seasonality and Co‐Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness—Valencia Region, Spain, 2010–2021
  di: George Shirreff, et al.
  Pubblicazione: (2024)